Literature DB >> 20230997

Comparison of real-time three-dimensional gadolinium-enhanced elliptic centric-ordered MR venography and two-dimensional time-of-flight MR venography of the intracranial venous system.

Jui-Hsun Fu1, Ping-Hong Lai, Chia-Chi Hsiao, Shang-Chieh Li, Mei-Jui Weng, Po-Ching Wang, Clement Kuen-Huang Chen.   

Abstract

BACKGROUND: To compare 3-dimensional gadolinium-enhanced elliptic centric-ordered (3D GEC) magnetic resonance venography (MRV) with traditional 2-dimensional time-of-flight (2D TOF) MRV for imaging of the intracranial venous system.
METHODS: Fifty-three patients underwent 2D and 3D MRV, whereby venous structures were evaluated by 2 neuroradiologists.
RESULTS: Of the 53 patients, 10 were diagnosed with dural venous sinus thrombosis and 12 with intracranial tumors. 3D GEC MRV displayed superior sensitivity/specificity (90.9%/96.8%) compared to 2D TOF MRV (63.6%/48.4%). Analysis of the areas under the receiver operating characteristic curves also showed superiority of 3D GEC (0.91) versus 2D TOF (0.53) MRV. Of the remaining 31 healthy patients, the rate of complete visibility of venous structures was also greater for 3D GEC (95.8%) than for 2D TOF (62.1%) MRV.
CONCLUSION: 3D GEC MRV is superior to 2D TOF MRV for providing more detail of the intracranial venous system, and can lead to better diagnosis of venous conditions. Copyright 2010 Elsevier. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20230997     DOI: 10.1016/S1726-4901(10)70027-7

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  2 in total

1.  Time-resolved MR angiography of the intracranial venous system: an alternative MR venography technique.

Authors:  Hasan Yiğit; Aynur Turan; Elif Ergün; Pınar Koşar; Uğur Koşar
Journal:  Eur Radiol       Date:  2011-11-20       Impact factor: 5.315

2.  A Preliminary Study of Neonatal Cranial Venous System by Color Doppler.

Authors:  Lu Yang Liu; Jin Ling Hong; Chang Jun Wu
Journal:  Biomed Res Int       Date:  2019-04-28       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.